survival rates for a common type of childhood cancer improved markedly at a leading medical center after doctors started using chemotherapy more aggressively a study showed last week in findings presented at the society for pediatric research's annual meeting dr laura bowman of st jude children's research hospital in memphis tenn said the overall four-year survival rate for neuroblastoma has improved from 37 to 55 during the last decade neuroblastoma which originates in the adrenal gland or nerve tissue near the spinal cord is the most common childhood solid tumor after brain tumors bowman noted if the cancer is not caught in its early stages it often spreads to the lymph nodes liver bone and bone marrow in the past doctors sometimes have been reluctant to rush childhood cancer patients into chemotherapy because of possible toxic side effects but about 10 years ago st jude doctors started using several front line chemotherapy drugs on neuroblastoma patients as soon as possible bowman said since that time the four-year survival rate for children younger than 1 year old whose disease is often not as advanced as in older youngsters has climbed from 48 to 89 the doctor said